GEG Tech manufacture exceptionally reliable and high-titer lentiviral vectors. Their newly developed non-integrative lentivirus technology (deficient for the integrase) offers unique nucleic acid delivery solutions with very low genotoxicity. For drug delivery purposes, GEG Tech also offer lentiviral vectors deficient for the reverse transcriptase ensuring no genotoxicity and excellent expression even into hard-to-transfect cells.
tebu-bio uses cookies on this website to ensure you the best possible
browsing experience each time you visit us. These small cookie files
are stored and used by your browser to personalise your visit. By
continuing your visit to the tebu-bio website without changing your
settings, you agree to use of these cookies. For more information,
please read our Privacy
Policy.